Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cystatin C.

David J Newman1

  • 1South West Thames Institute for Renal Research, St Helier Hospital, Carshalton, Surrey, UK. d.j.newman@btinternet.com

Annals of Clinical Biochemistry
|April 4, 2002
PubMed
Summary
This summary is machine-generated.

Cystatin C shows promise as a replacement for creatinine in assessing kidney function (GFR). Despite its potential, widespread clinical adoption is limited by concerns regarding non-renal factors and a need for more clinical studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unlocking the metabolic potential of endophytic fungi through epigenetics: a paradigm shift for natural product discovery and plant-microbe interactions.

Natural product reports·2025
Same author

The Extraordinary Benefit of Nature's Chemistry to Health, Society, and the Economy.

Journal of natural products·2025
Same author

Two New Halimanes with a γ-Lactone from Croton argyratus.

Chemical & pharmaceutical bulletin·2025
Same author

Editorial for the Special Issue in Honor of Sheo Singh.

Journal of natural products·2025
Same author

Isolation, Characterization, and Antiproliferative Activity of Terpenoids from the Tropical Plant <i>Turraea delphinensis</i>.

Journal of natural products·2024
Same author

Something 'Old, New, Borrowed, or Blue', the Search for Mother Nature's Bioactive Agents.

Current opinion in biotechnology·2024
Same journal

Stability of Electrolytes in Whole Blood at Room Temperature Prior to Centrifugation: implications for Clinical Analysis.

Annals of clinical biochemistry·2026
Same journal

Comparison of Jaffe, Enzymatic, and Mass Spectrometric Methods for Creatinine Measurement in Protein-Positive and Hemoglobin-Positive Urine Samples.

Annals of clinical biochemistry·2026
Same journal

Limitations of spectrophotometry in the analysis of cerebrospinal fluid bilirubin.

Annals of clinical biochemistry·2026
Same journal

Commentary on the impact of lithium heparin vacutainer tubes on daily cerebrospinal fluid analysis.

Annals of clinical biochemistry·2026
Same journal

Routine laboratory triage for NT-proBNP elevation may reflect cardiorenal frailty as much as heart failure specificity.

Annals of clinical biochemistry·2026
Same journal

From interpretable NT-proBNP prediction to equitable laboratory stewardship.

Annals of clinical biochemistry·2026
See all related articles

Area of Science:

  • Biochemistry
  • Nephrology
  • Clinical Chemistry

Background:

  • Creatinine and creatinine clearance have known analytical and clinical limitations for assessing glomerular filtration rate (GFR).
  • Cystatin C has been researched for over 20 years as a potential biochemical marker for GFR assessment.
  • Limited clinical adoption of cystatin C despite its research history.

Purpose of the Study:

  • To review the limitations of creatinine and creatinine clearance for GFR assessment.
  • To assess the utility of cystatin C as a replacement marker for GFR.
  • To compare the measurement, sensitivity, and specificity of cystatin C and creatinine for GFR changes.

Main Methods:

  • Review of existing literature comparing creatinine and cystatin C measurements.

Related Experiment Videos

  • Analysis of sensitivity and specificity of both markers for detecting changes in GFR.
  • Evaluation of cystatin C as a screening test for renal dysfunction and progression.

    • Main Results:

    • Cystatin C is a promising marker for GFR, potentially superior to creatinine as a screening test.
    • Concerns remain regarding non-renal influences on cystatin C levels, such as steroid therapy and malignancy.
    • Lack of prospective studies confirming the prognostic significance of cystatin C.

    Conclusions:

    • Cystatin C demonstrates superiority as a screening test for renal dysfunction compared to creatinine.
    • Further research is needed to address non-renal influences and validate the prognostic value of cystatin C in clinical practice.